Annotated Medicine and Device Lists


Ceftazidime

This medicine is present in:

List Section Observation
Peru 6.2.1.2 Cephalosporins No observations
Ecuador Essential Medicines List - Ecuador No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Antibiotics Cephalosporins 3rd Gen. No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 01 ANTIBACTERIANOS PARA USO SISTÉMICO No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.01 ANTIBIOTICS Others observations:
pentahydrate
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 01 ANTIBACTERIANOS PARA USO SISTÉMICO No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.01 ANTIBIOTICS Others observations:
pentahydrate

This medicine is present in:

List Section Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.02. ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
BULBO
Chile. Formulario Nacional de Medicamentos. 2005 06.02. ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 02. Antibióticos No observations
El Salvador - 2019 ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.2. Other antibacterial No observations

Information Resources: Ceftazidime

Loading ...
Loading ...
Loading ...
No information available